GEODE CAPITAL MANAGEMENT, LLC

Holdings History for 4D Molecular Therapeutics, Inc. - Common Stock, par value $0.0001 per share (FDMT)

Symbol: FDMT on Nasdaq
Investment type: Equity / Common Stock, par value $0.0001 per share

Shares, Excluding Options vs Price

Value, Excluding Options

Holdings date	Weight	Change	Value $	Shares	Change	Activity %	Price	All Holders
31 Dec 2025	0%	+0%	$7,591,665	1,012,025	+98,506	+11%	$7.50	Q4 2025
30 Sep 2025	0%	-0%	$7,940,280	913,519	-5,014	-0.55%	$8.69	Q3 2025
30 Jun 2025	0%	-0%	$3,408,466	918,533	-44,736	-4.6%	$3.71	Q2 2025
31 Mar 2025	0%	-0%	$3,112,108	963,269	-48,893		$3.23	Q1 2025
31 Dec 2024	0%	-0%	$5,639,030	1,012,162	-24,383	-2.4%	$5.57	Q4 2024
30 Sep 2024	0%	-0%	$11,207,066	1,036,545	-24,346	-2.3%	$10.81	Q3 2024
30 Jun 2024	0%	+0%	$22,272,188	1,060,891	+188,228	+22%	$20.99	Q2 2024
31 Mar 2024	0%	+0%	$27,807,200	872,663	+94,501	+12%	$31.86	Q1 2024
31 Dec 2023	0%	+0%	$15,766,991	778,162	+36,497	+4.9%	$20.26	Q4 2023
30 Sep 2023	0%	+0%	$9,442,385	741,665	+51,888	+7.5%	$12.73	Q3 2023
30 Jun 2023	0%	+0%	$12,464,276	689,777	+111,855	+19%	$18.07	Q2 2023
31 Mar 2023	0%	+0%	$9,934,485	577,922	+16,185	+2.9%	$17.19	Q1 2023
31 Dec 2022	0%	+0%	$12,476,000	561,737	+32,801	+6.2%	$22.21	Q4 2022
30 Sep 2022	0%	+0%	$4,252,000	528,936	+36,111	+7.3%	$8.04	Q3 2022
30 Jun 2022	0%	+0%	$3,439,000	492,825	+14,202	+3%	$6.98	Q2 2022
31 Mar 2022	0%	-0%	$7,236,000	478,623	-3,814	-0.79%	$15.12	Q1 2022
31 Dec 2021	0%	+0%	$10,584,000	482,437	+140,219	+41%	$21.94	Q4 2021
30 Sep 2021	0%	+0%	$9,229,000	342,218	+174,784	+104%	$26.97	Q3 2021
30 Jun 2021	0%	+0%	$4,031,000	167,434	+21,136	+14%	$24.08	Q2 2021
31 Mar 2021	0%	+0%	$6,346,000	146,298	+133,518	+1045%	$43.38	Q1 2021
31 Dec 2020	0%	+0%	$529,000	12,780	+12,780	NEW	$41.39	Q4 2020

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.